Preferred Label : adverse effects;
CISMeF synonym : Adverse Drug Reaction;
MeSH synonym : injurious effects; side effects; undesirable effects;
Origin ID : Q000009;
UMLS CUI : C0001688;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Metaterm(s)
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
https://www.has-sante.fr/jcms/c_2058872/fr/iqss-2020-ete-ortho-evenements-thrombo-emboliques-apres-pose-de-prothese-totale-de-hanche-hors-fracture-ou-de-genou
2026
false
false
false
France
arthroplasty, replacement, knee
arthroplasty, replacement, hip
quality indicators, health care
patient safety
deep vein thrombosis
pulmonary embolism
technical report
thromboembolism
---
https://ansm.sante.fr/tableau-marr/sel-de-fer-injectable
2025
false
false
false
France
French
risk management
iron compounds
iron, parenteral preparations
patient education handout
guidelines for drug use
injections, intravenous
infusions, intravenous
iron compounds
anaphylaxis
drug hypersensitivity
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide
---
https://ansm.sante.fr/tableau-marr/denosumab
2025
false
false
false
France
French
risk management
Denosumab
patient education handout
drug information
osteonecrosis
Osteonecrosis of Jaw
---
https://www.cbip.be/fr/articles/4494?folia=4486
2025
false
false
false
Belgium
French
journal article
drug information
dipyrone
agranulocytosis
risk
---
https://ansm.sante.fr/informations-de-securite/specialites-contenant-du-thiocolchicoside-rappels-et-nouvelles-recommandations-concernant-le-risque-potentiel-de-genotoxicite?
2025
false
false
false
France
French
pharmacovigilance note
risk management
thiocolchicoside
Genotoxicity
administration, oral
injections, intramuscular
thiocolchicoside
Male
thiocolchicoside
---
https://ansm.sante.fr/actualites/vapotage-de-substances-psychoactives-hors-nicotine-des-pratiques-plus-risquees-quon-ne-le-pense
2025
false
false
false
France
French
Vaping
vigilance note
psychotropic drugs
risk
Synthetic cannabinoid (substance)
cannabinoids
adolescent
patient education handout
guideline
---
https://ansm.sante.fr/actualites/morcellateurs-utilises-en-gynecologie-les-recommandations-de-lansm-sont-bien-respectees-par-les-fabricants-distributeurs
2025
false
false
false
France
French
health surveys
morcellators
product surveillance, postmarketing
Morcellation
uterine neoplasms
fibroid uterus
risk management
Tumor Cell Seeding related to Procedure
neoplasm seeding
Morcellation
Morcellation
---
https://ansm.sante.fr/actualites/benfluorex-conclusions-du-rapport-2020-2023-de-surveillance-des-cas-dhypertension-arterielle-pulmonaire
2025
false
false
false
France
French
technical report
health surveys
hypertension, pulmonary
benfluorex
pharmacovigilance
benfluorex
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2025-13-16-janvier
2025
false
false
false
France
French
Toxic Optic Neuropathy
Nonarteritic anterior ischemic optic neuropathy
semaglutide
risk assessment
risk
semaglutide
drug information
europe
injections, subcutaneous
Glucagon-Like Peptide-1 Receptor Agonists
product surveillance, postmarketing
---
https://ansm.sante.fr/tableau-marr/pseudoephedrine
2025
false
false
false
France
French
pseudoephedrine
risk management
drug information
patients guideline
nasal decongestants
drug combinations
administration, oral
pseudoephedrine, combinations
common cold
---
https://ansm.sante.fr/tableau-marr/ranibizumab-4
2025
false
false
false
France
French
drug information
patient education handout
risk management
Ranibizumab
Drug-Related side effects and adverse reactions
eye diseases
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release
solution for injection (clinical drug)
intravitreal injections
ranibizumab
---
https://www.cbip.be/fr/articles/4495?folia=4486
2025
false
false
false
Belgium
French
journal article
pharmacovigilance note
attention deficit disorder with hyperactivity
cardiovascular diseases
risk
Long-term drug therapy (procedure)
Observational Studies as Topic
methylphenidate
central nervous system stimulants
continuity of patient care
child
adult
Lisdexamfetamine Dimesylate
Atomoxetine Hydrochloride
centrally acting sympathomimetics
---
https://ansm.sante.fr/tableau-marr/denosumab-1
2025
false
false
false
France
French
risk management
Denosumab
denosumab
Drug-Related side effects and adverse reactions
patient education handout
drug information
osteonecrosis
jaw diseases
Osteonecrosis of Jaw
---
https://ansm.sante.fr/actualites/lansm-prend-une-decision-de-police-sanitaire-concernant-les-produits-de-tatouage-perma-blend-maquillage-permanent
2025
false
false
false
France
French
vigilance note
Permanent Tattoo Ink Cosmetic Product
Disorder of skin caused by tattoo ink (disorder)
Tattooing of permanent makeup (procedure)
Tattoo dye (substance)
Product contamination microbial
cosmetics
---
https://www.has-sante.fr/jcms/p_3589971/fr/sam-de-l-ansm-sur-la-codeine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-afin-de-reduire-le-risque-de-mesusage-d-addiction-et-de-surdosage
2025
false
false
false
France
drug prescriptions
guideline
codeine
substance-related disorders
Drug Misuse
prescription drug misuse
medical order entry systems
algorithms
risk management
codeine
drug overdose
---
https://ansm.sante.fr/tableau-marr/tolcapone
2025
false
false
false
France
French
risk management
continuity of patient care
Chemical and Drug Induced Liver Injury
neuroleptic malignant syndrome
Tolcapone
tolcapone
liver function tests
drug information
patient education handout
---
https://ansm.sante.fr/actualites/implants-de-renfort-parietal-pour-le-traitement-des-hernies-abdominales-et-inguinales-nos-actions-pour-assurer-la-securite-des-patients
2025
false
false
false
France
French
equipment and supplies note
product surveillance, postmarketing
hernia, inguinal
hernia, abdominal
prostheses and implants
---
https://ansm.sante.fr/actualites/fluoroquinolones-nous-rappelons-limportance-du-bon-usage-de-ces-antibiotiques
2025
false
false
false
France
French
guidelines for drug use
fluoroquinolones
fluoroquinolones
anti-bacterial agents
anti-bacterial agents
administration, oral
injections
fluoroquinolones
Off-Label use
drug interactions
technical report
pharmacovigilance
france
Drug-Related side effects and adverse reactions
ciprofloxacin
levofloxacin
ofloxacin
norfloxacin
Moxifloxacin
lomefloxacin
delafloxacin
---
https://ansm.sante.fr/tableau-marr/tremelimumab
2025
false
false
false
France
French
tremelimumab
tremelimumab
risk management
drug information
patient education handout
Immune-Mediated Adverse Reaction
Drug-Related side effects and adverse reactions
signs and symptoms
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/actualites/des-pratiques-illegales-dinjection-de-toxine-botulinique-mettent-en-danger-les-utilisateurs
2025
false
false
false
France
French
vigilance note
quackery
botulism
france
botulinum toxins
cosmetic techniques
---
https://ansm.sante.fr/tableau-marr/testosterone-enanthate-de
2025
false
false
false
France
French
risk management
testosterone enanthate
testosterone enanthate
risk
guidelines for drug use
testosterone
injections, intramuscular
Pulmonary oil microembolism (disorder)
---
https://ansm.sante.fr/actualites/contraception-et-risque-de-meningiome-nouvelles-recommandations
2025
false
false
false
France
French
risk management
contraceptives, oral, hormonal
meningioma
patients guideline
guidelines for drug use
continuity of patient care
risk
desogestrel
risk factors
meningioma
---
https://ansm.sante.fr/tableau-marr/etranacogene-dezaparvovec
2025
false
false
false
France
French
risk management
Etranacogene Dezaparvovec
etranacogene dezaparvovec
guidelines for drug use
patients guideline
popular works
thromboembolism
Drug-Related side effects and adverse reactions
Chemical and Drug Induced Liver Injury
gene therapy
Gene Therapy Agents
semen
blood
DNA-Mediated Gene Transfer
pregnancy
gene transfer, horizontal
---
https://www.cbip.be/fr/articles/4518?folia=4503
2025
false
false
false
Belgium
French
journal article
drug information
hot flashes
fezolinetant
fezolinetant
fezolinetant
continuity of patient care
liver function tests
Chemical and Drug Induced Liver Injury
risk management
---
https://www.afmps.be/fr/news/les_medicaments_de_therapie_innovante_non_reglementes_presentent_de_graves_risques_pour_la
2025
false
false
false
Belgium
French
innovative therapies
risk
patient safety
pharmacovigilance note
Dendritic Cell Therapy
immunotherapy, adoptive
dendritic cells
legislation, drug
europe
belgium
---
https://ansm.sante.fr/actualites/anti-inflammatoires-non-steroidiens-ains-chez-les-femmes-enceintes-ameliorer-linformation-sur-les-risques-pour-un-meilleur-usage
2025
false
false
false
France
French
anti-inflammatory agents, non-steroidal
pregnancy
Pregnant People
risk management
risk
drug information
anti-inflammatory agents, non-steroidal
patients guideline
pain
fever
inflammation
abnormalities, drug-induced
---
https://ansm.sante.fr/actualites/lansm-accompagne-la-campagne-vaccinale-contre-le-chikungunya-vaccin-ixchiq
2025
false
false
false
France
French
drug information
vaccination
Chikungunya Fever
Chikungunya vaccine (live)
reunion
patient education handout
product surveillance, postmarketing
viral vaccines
---
https://respire-asso.org/
false
France
French
air pollution
association
---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline
---
https://ansm.sante.fr/tableau-marr/mavacamten
2025
false
false
false
France
French
risk management
mavacamten
mavacamten
mavacamten
administration, oral
patients guideline
guidelines for drug use
fetus
pregnancy
embryo
drug interactions
heart failure, systolic
Fetal exposure to drug (situation)
Cytochrome P-450 CYP2C19 Inhibitors
Cytochrome P-450 CYP3A4 Inhibitors
Cytochrome P450 family 2 subfamily C member 19 intermediate metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 ultra-rapid metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 normal metabolizer (finding)
patient education handout
---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2025
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal
product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel
---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral
---
https://ansm.sante.fr/tableau-marr/lauromacrogol-400
2025
false
false
false
France
French
risk management
guidelines for drug use
Polidocanol
polidocanol
patients guideline
Polidocanol
Drug-Related side effects and adverse reactions
continuity of patient care
Polidocanol
drug compounding
---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording
---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2025
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms
defrosting
---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2025
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain
---
https://ansm.sante.fr/tableau-marr/cladribine
2025
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests
---
https://ansm.sante.fr/tableau-marr/alpelisib
2025
false
false
false
France
French
guidelines for drug use
administration, oral
Drug-Related side effects and adverse reactions
alpelisib
Alpelisib
Alpelisib
continuity of patient care
Hyperglycaemic hyperosmolar nonketotic syndrome
hyperglycemia
ketosis
thiazoles
thiazoles
---
https://ansm.sante.fr/tableau-marr/esketamine
2025
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine
---
https://ansm.sante.fr/tableau-marr/fingolimod
2025
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management
---
https://ansm.sante.fr/tableau-marr/clozapine
2025
false
false
false
France
French
clozapine
risk management
patient education handout
blood cell count
forms
agranulocytosis
continuity of patient care
drug monitoring
---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
https://www.cbip.be/fr/articles/4475?folia=4464
2025
false
false
false
Belgium
French
pharmacovigilance note
journal article
Olmesartan Medoxomil
Adverse reaction caused by olmesartan (disorder)
risk
intestinal diseases
---
https://ansm.sante.fr/actualites/lautorisation-de-mise-sur-le-marche-du-medicament-progesterone-retard-pharlon-caproate-dhydroxyprogesterone-est-suspendue
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure
---
https://ansm.sante.fr/informations-de-securite/suspension-des-autorisations-de-mise-sur-le-marche-des-medicaments-contenant-du-caproate-dhydroxyprogesterone
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure
guideline
---
https://ansm.sante.fr/informations-de-securite/crayon-au-nitrate-dargent-restriction-des-indications-et-rappel-des-risques
2024
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
silver nitrate
silver nitrate
risk
---
https://ansm.sante.fr/actualites/pronostic-a-18-mois-des-cas-de-myocardite-attribuables-a-la-vaccination-arnm-contre-le-covid-19-le-jama-publie-les-resultats-dune-etude-de-pharmaco-epidemiologie-realisee-par-epi-phare
2024
false
false
false
France
French
drug information
COVID-19 Vaccines
mRNA Vaccines
myocarditis
myocarditis
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger
ribonucleic acid (medicinal product)
prognosis
france
covid-19, RNA-based vaccine
COVID-19
mRNA COVID-19 Vaccine
cohort studies
---
https://ansm.sante.fr/tableau-marr/voriconazole
2024
false
false
false
France
French
risk management
Voriconazole
antifungal agents
drug information
patients guideline
dermatitis, phototoxic
dermatitis, phototoxic
risk
skin neoplasms
skin neoplasms
Skin Squamous Cell Carcinoma
Skin Squamous Cell Carcinoma
voriconazole
---
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/aout-2024.html#a2_a1
2024
false
false
false
Canada
French
pregnancy
Pregnant People
pharmacovigilance note
calcium carbonate
antacids
Milk-Alkali syndrome
risk
gastroesophageal reflux
calcium carbonate
---
https://www.afsos.org/wp-content/uploads/2024/09/AFSOS-referentiel-NVAI_0824.pdf
2024
false
false
false
France
antineoplastic agents
chemotherapy-induced nausea and vomiting
antiemetics
algorithms
nausea
guideline
---
https://ansm.sante.fr/tableau-marr/ranibizumab-3
2024
false
false
false
France
French
risk management
Ranibizumab
package leaflet
patient education handout
drug information
Ranibizumab
---
https://www.cbip.be/fr/articles/4404?folia=4395
2024
false
false
false
Belgium
French
proton pump inhibitors
infant
child
journal article
drug information
serious infection
Infections
---
https://ansm.sante.fr/tableau-marr/brigatinib
2024
false
false
false
France
French
risk management
brigatinib
patients guideline
patient education handout
drug information
Pneumonitis
Interstitial lung disease (disorder)
brigatinib
administration, oral
antineoplastic agents
protein kinase inhibitors
---
https://ansm.sante.fr/tableau-marr/trastuzumab-deruxtecan
2024
false
false
false
France
French
risk management
trastuzumab deruxtecan
trastuzumab deruxtecan
infusions, intravenous
Antineoplastic Agents, Immunological
medication errors
guidelines for drug use
lung diseases
patient education handout
patients guideline
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
---
https://ansm.sante.fr/tableau-marr/tebentafusp
2024
false
false
false
France
French
patients guideline
guidelines for drug use
drug information
risk management
tebentafusp
tebentafusp
infusions, intravenous
Cytokine Release Syndrome
signs and symptoms
antineoplastic agents
---
https://ansm.sante.fr/actualites/tramadol-et-codeine-devront-etre-prescrits-sur-une-ordonnance-securisee-des-le-1er-decembre
https://ansm.sante.fr/actualites/decision-du-24-09-2024-portant-application-dune-partie-de-la-reglementation-des-stupefiants-et-fixant-des-durees-de-prescription-tramadol-codeine
2024
false
false
false
France
French
patients guideline
guidelines for drug use
tramadol
codeine
drug prescriptions
legislation, pharmacy
prescription drug diversion
prescription drug misuse
opioid-related disorders
risk
risk management
analgesics, opioid
dihydrocodeine
Duration of Therapy
---
https://www.cbip.be/fr/articles/4407?folia=4395
2024
false
false
false
Belgium
French
minoxidil
administration, cutaneous
child
hypertrichosis
drug information
journal article
risk
---
https://ansm.sante.fr/actualites/prevention-de-la-bronchiolite-du-nourrisson-les-premieres-donnees-de-pharmacovigilance-confirment-le-profil-de-securite-du-nirsevimab-beyfortus
2024
false
false
false
France
French
bronchiolitis, viral
infant, newborn
infant
pharmacovigilance
respiratory syncytial virus infections
nirsevimab
nirsevimab
risks and benefits
Benefit-Risk assessment
hospitalization
investigative report
drug information
technical report
nirsevimab
---
https://www.cbip.be/fr/articles/4410?folia=4409
2024
false
false
false
Belgium
French
pregnancy
hypoglycemic agents
drug information
journal article
diabetes mellitus, type 2
hypoglycemic agents
risk assessment
congenital abnormalities
Maternal Preconception Stage
practice guidelines as topic
belgium
insulin
metformin
administration, oral
injections, subcutaneous
---
https://ansm.sante.fr/tableau-marr/ravulizumab
2024
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized
---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense
---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections
risk
---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines
---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases
elranatamab
---
https://ansm.sante.fr/informations-de-securite/adagrasib-risque-potentiel-deffets-indesirables-cutanes-severes
2024
false
false
false
France
French
pharmacovigilance note
risk
adagrasib
stevens-johnson syndrome
epidermal necrolysis, toxic
adagrasib
antineoplastic agents
Adagrasib Regimen
---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection
---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy
drug prescriptions
---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child
---
https://ansm.sante.fr/tableau-marr/rituximab-3
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Rituximab
Rituximab
risk management
continuity of patient care
child
infusions, intravenous
leukoencephalopathy, progressive multifocal
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/cemiplimab
2024
false
false
false
France
French
risk management
patients guideline
cemiplimab
Antineoplastic Agents, Immunological
infusions, intravenous
cemiplimab
drug monitoring
lymphohistiocytosis, hemophagocytic
drug information
lymphohistiocytosis, hemophagocytic
---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2024
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy
---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2024
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel
---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents
---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2024
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
Safety-Based drug withdrawals
---
https://ansm.sante.fr/tableau-marr/fenfluramine
2024
false
false
false
France
French
administration, oral
risk management
guidelines for drug use
pharmacovigilance note
fenfluramine
fenfluramine
continuity of patient care
drug monitoring
hypertension, pulmonary
Drug-Related side effects and adverse reactions
heart valve diseases
patients guideline
Off-Label use
---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab
---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout
---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)
---
https://ansm.sante.fr/tableau-marr/eculizumab
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
Drug-Related side effects and adverse reactions
meningococcal vaccines
---
https://ansm.sante.fr/tableau-marr/etonogestrel
2024
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins
---
http://publications.msss.gouv.qc.ca/msss/document-001040/
2024
false
true
false
Canada
immunization schedule
vaccines
measles-mumps-rubella vaccine
meningococcal vaccines
pneumococcal vaccines
influenza vaccines
Diphtheria-Tetanus-Pertussis vaccine
rotavirus vaccines
child
infant
popular works
vaccination
---
http://publications.msss.gouv.qc.ca/msss/document-000454/
2024
false
true
false
Canada
measles
measles
measles vaccine
popular works
measles vaccine
---
https://ansm.sante.fr/tableau-marr/teriflunomide
2024
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines
---
https://ansm.sante.fr/tableau-marr/acitretine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/alitretinoine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
Drug-Related side effects and adverse reactions
Alitretinoin
Alitretinoin
---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal
---
https://ansm.sante.fr/tableau-marr/emicizumab
2024
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
emicizumab
continuity of patient care
antibodies, bispecific
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/isotretinoine
2024
false
false
false
France
French
administration, oral
isotretinoin
risk management
acne vulgaris
isotretinoin
teratogens
pregnancy
contraception
mental disorders
dyslipidemias
Chemical and Drug Induced Liver Injury
patient education handout
forms
pancreatitis
guidelines for drug use
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide
---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2024
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness
---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/rituximab
2024
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding
---
https://ansm.sante.fr/tableau-marr/sonidegib
2024
false
false
false
France
French
risk management
sonidegib
teratogens
pregnancy
abnormalities, drug-induced
contraception
pregnancy tests
antineoplastic agents
fetal death
patient education handout
guidelines for drug use
guideline
sonidegib
biphenyl compounds
pyridines
---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet
---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2024
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid
---
https://ansm.sante.fr/tableau-marr/vandetanib
2024
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
RET Gene Mutation
guidelines for drug use
piperidines
quinazolines
piperidines
quinazolines
---
https://sfsep.org/sep-et-vaccinations/
2024
true
false
false
false
France
guidelines as topic
professional practice
patient care management
drug interactions
Immunosuppression Therapy
guideline
multiple sclerosis
multiple sclerosis
multiple sclerosis, nos
vaccination, nos
preventive immunization/medication
vaccination
Multiple sclerosis
multiple sclerosis
---
https://ansm.sante.fr/informations-de-securite/oxbryta-voxelotor-suspension-de-lautorisation-de-mise-sur-le-marche-de-lunion-europeenne
https://ansm.sante.fr/actualites/oxbryta-voxelotor-conduite-a-tenir-suite-a-la-suspension-de-lautorisation-de-mise-sur-le-marche
2024
false
false
false
France
French
Safety-Based drug withdrawals
voxelotor
pharmacovigilance note
voxelotor
guidelines for drug use
drugs, investigational
france
europe
hematologic agents
Vaso-Occlusive Crisis
---
https://ansm.sante.fr/actualites/reevaluation-europeenne-de-la-balance-benefice-risque-des-medicaments-contenant-du-finasteride-ou-du-dutasteride
2024
false
false
false
France
French
drug information
finasteride
Dutasteride
product surveillance, postmarketing
pharmacovigilance
---
https://www.cbip.be/fr/articles/4417?folia=4409
2024
false
false
false
Belgium
French
journal article
drug information
vitamin B 6
vitamin B 6
nervous system diseases
Iatrogenic neuropathy (disorder)
Long-term current use of drug therapy (situation)
vitamin B 6
---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-dernieres-donnees-confirment-de-nouveau-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus infections
vaccination
papillomavirus vaccines
papillomavirus vaccines
drug information
pharmacovigilance
safety management
patient safety
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)
---
https://www.cbip.be/fr/articles/4425?folia=4409
2024
false
false
false
Belgium
French
risk
journal article
pharmacovigilance note
pulmonary disease, chronic obstructive
Chronic obstructive pulmonary disease exacerbation
Gabapentin
Pregabalin
cohort studies
---
https://ansm.sante.fr/informations-de-securite/acetate-de-medroxyprogesterone-en-suspension-injectable-depo-prodasone-500-mg-risque-de-meningiome-et-mesures-de-reduction-du-risque
2024
false
false
false
France
French
risk management
meningioma
medroxyprogesterone acetate
injections, intramuscular
medroxyprogesterone
guidelines for drug use
---
https://www.cbip.be/fr/articles/4440?folia=4434
2024
false
false
false
Belgium
French
journal article
drug information
cholinergic antagonists
cognition disorders
memory
cognition
aged
---
https://www.cbip.be/fr/articles/4448?folia=4434
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
cyclosporine
risk
fibroadenoma
premenopause
---
https://ansm.sante.fr/tableau-marr/enfortumab-vedotin
2024
false
false
false
France
French
risk management
enfortumab vedotin
enfortumab vedotin
drug information
patients guideline
Drug-Related side effects and adverse reactions
signs and symptoms
stevens-johnson syndrome
epidermal necrolysis, toxic
continuity of patient care
---
https://ansm.sante.fr/tableau-marr/tislelizumab
2024
false
false
false
France
French
risk management
tislelizumab
tislelizumab
patient education handout
patients guideline
drug information
Drug-Related side effects and adverse reactions
signs and symptoms
Pneumonitis
colitis
hepatitis
endocrine system diseases
drug eruptions
nephritis
Infusion-Related Reaction
---
https://ansm.sante.fr/tableau-marr/adamts13r
2024
false
false
false
France
French
risk management
ADAMTS13 Protein
guidelines for drug use
drug hypersensitivity
drug hypersensitivity
signs and symptoms
patient education handout
enzyme replacement therapy
adult
child
congenital thrombotic thrombocytopenic purpura
ADAMTS13 Protein
recombinant proteins
---
https://ansm.sante.fr/tableau-marr/nivolumab-relatlimab
2024
false
false
false
France
French
patients guideline
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
signs and symptoms
drug information
drug combinations
Nivolumab
relatlimab
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-decembre-2024-25-28-novembre
2024
false
false
false
France
French
pharmacovigilance
doxycycline
risk assessment
drug information
suicidal ideation
anti-bacterial agents
---
https://ansm.sante.fr/tableau-marr/topiramate
2024
false
false
false
France
French
risk management
Topiramate
teratogens
abnormalities, drug-induced
guideline
guidelines for drug use
patient education handout
Neurodevelopmental Disorders
prenatal exposure delayed effects
pregnancy
Autism Spectrum Disorder
contraception
female
adolescent
adult
Female of Childbearing Potential
fetus
---
https://ansm.sante.fr/tableau-marr/carbamazepine
2024
false
false
false
France
French
risk management
carbamazepine
teratogens
pregnancy
abnormalities, drug-induced
guideline
fetus
Neurodevelopmental Disorders
Female of Childbearing Potential
contraception
adolescent
adult
guidelines for drug use
carbamazepine
---
https://ansm.sante.fr/actualites/de-nouvelles-donnees-sur-le-risque-de-meningiome-associe-a-la-prise-de-progestatifs-en-contraception-orale
2024
false
false
false
France
French
drug information
meningioma
contraceptives, oral
levonorgestrel
risk assessment
desogestrel
technical report
continuity of patient care
---
https://ansm.sante.fr/tableau-marr/acide-cholique
2024
false
false
false
France
French
cholic acid
risk management
guideline
cholic acid
administration, oral
bile acid synthesis defect, congenital, 2
bile acid synthesis defect, congenital, 1
signs and symptoms
drug information
bile acid synthesis defect, congenital, 2
bile acid synthesis defect, congenital, 1
---
https://www.cochrane.org/fr/CD007693/ORAL_fluorure-topique-comme-cause-de-la-fluorose-dentaire-chez-lenfant
2024
false
United Kingdom
France
French
meta-analysis
fluorosis, dental
fluorides, topical
child
french abstract
---
https://www.cochrane.org/fr/CD008879/COLOCA_une-alimentation-complementaire-avant-loperation-est-elle-preferable-une-alimentation-normale-chez
2024
false
France
United Kingdom
French
french abstract
meta-analysis
digestive system surgical procedures
preoperative care
dietary supplements
treatment outcome
enteral nutrition
parenteral nutrition
postoperative complications
---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections
---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory
syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
2024
false
false
false
France
French
risk management
valproic acid
Male
Neurodevelopmental Disorders
Chimeric antigen receptor T-cell therapy
genetic therapy
Secondary Carcinoma
Chimeric Antigen Receptor Therapy
immunotherapy, adoptive
pharmacovigilance note
---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous
---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations
---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form
---
https://www.cbip.be/fr/articles/4263?folia=4259
2024
false
false
false
Belgium
French
journal article
drug information
glucocorticoids
administration, oral
Long-term current use of drug therapy (situation)
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions
---
https://ansm.sante.fr/actualites/enceinte-les-medicaments-cest-toujours-pas-nimporte-comment
2024
false
false
false
France
French
drug information
pregnancy
Pregnant People
pharmaceutical preparations
abnormalities, drug-induced
---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab
---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related
---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous
Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents
---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout
---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiomes-intracraniens-le-bmj-publie-une-etude-epidemiologique-francaise
2024
false
false
false
France
French
pharmacovigilance note
epidemiologic studies
france
meningioma
meningioma
medroxyprogesterone acetate
risk assessment
Product containing only levonorgestrel in intrauterine dose form (medicinal product
form)
levonorgestrel
injections, intramuscular
plastic iud with progestogen
administration, intravaginal
progestins
intrauterine devices
medroxyprogesterone
---
https://www.cbip.be/fr/articles/4284?folia=4275
2024
false
false
false
Belgium
French
Dutch
journal article
pseudoephedrine
belgium
europe
---
https://ansm.sante.fr/informations-de-securite/en-cas-de-rhume-ne-pas-utiliser-de-medicaments-a-base-de-pseudoephedrine-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
pseudoephedrine
administration, oral
pharmacovigilance note
nasal decongestants
common cold
risk factors
risk
pseudoephedrine
pseudoephedrine, combinations
guidelines
---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents
---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents
---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child
---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording
---
https://ansm.sante.fr/tableau-marr/natalizumab-1
2024
false
false
false
France
French
Natalizumab
risk management
Natalizumab
natalizumab
guidelines for drug use
patient education handout
continuity of patient care
Drug-Related side effects and adverse reactions
opportunistic infections
leukoencephalopathy, progressive multifocal
immunologic factors
immunologic factors
multiple sclerosis
---
https://www.cbip.be/fr/articles/4316?folia=4305
2024
false
false
false
Belgium
French
journal article
Selective Serotonin Reuptake Inhibitors
risk
gastrointestinal hemorrhage
---
https://www.cbip.be/fr/articles/4328?folia=4319
2024
false
false
false
Belgium
French
journal article
valproic acid
risk management
Exposure to anticonvulsant (event)
paternal exposure
Neurodevelopmental Disorders
child
---
https://ansm.sante.fr/actualites/sante-des-enfants-nes-apres-assistance-medicale-a-la-procreation-pas-daugmentation-globale-du-risque-de-cancer-mais-une-legere-augmentation-du-risque-de-leucemie-nest-pas-exclue
2024
false
false
false
France
French
vigilance note
reproductive techniques, assisted
---
http://beh.santepubliquefrance.fr/beh/2024/9/2024_9_2.html
2024
false
false
false
France
alcoholic beverages
consumer health information
journal article
alcohol drinking
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mai-2024-13-16-mai
2024
false
false
false
France
French
drug information
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
europe
---
https://www.cbip.be/fr/articles/4320?folia=4319
2024
false
false
false
Belgium
French
patient safety
acetaminophen
pregnancy trimester, third
journal article
fetus
In Utero Drug Exposure
infant, newborn
Premature Closure of Ductus Arteriosus
---
https://www.cbip.be/fr/articles/4344?folia=4336
2024
false
false
false
Belgium
French
journal article
pharmacovigilance note
Denosumab
hypocalcemia
denosumab
renal insufficiency
---
https://ansm.sante.fr/tableau-marr/velmanase-alfa
2024
false
false
false
France
French
risk management
continuity of patient care
Drug-Related side effects and adverse reactions
guidelines for drug use
velmanase alfa
Velmanase Alfa
infusions, intravenous
enzyme replacement therapy
drug hypersensitivity
home infusion therapy
medication errors
Velmanase Alfa
anaphylaxis
Infusion-Related Reaction
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-juin-2024-10-13-juin
2024
false
false
false
France
French
pharmacovigilance note
risk assessment
risk
dipyrone
agranulocytosis
gene therapy
Chimeric Antigen Receptor T-cells
Antineoplastic Agents, Immunological
Therapy-Associated cancer
Chimeric Antigen Receptor Therapy
---
https://www.cbip.be/fr/articles/4345?folia=4336
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
mianserin
mianserin
Compulsive Sexual Behavior Disorder
antidepressive agents, second-generation
aged
---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiome-renforcement-des-conditions-de-prescription-et-de-delivrance-de-depo-provera-150-mg-3-ml-et-colprone-5-mg
2024
false
false
false
France
French
guidelines for drug use
meningioma
risk management
legislation, drug
medroxyprogesterone acetate
Drug-Related side effects and adverse reactions
medrogestone
progesterone congeners
medrogestone
medroxyprogesterone
---
https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-medroxyprogesterone-depo-provera-150-mg-3-ml-et-de-medrogestone-colprone-5-mg-liees-au-risque-de-meningiome-a-compter-du-1er-juillet-2024
2024
false
false
false
France
French
guidelines for drug use
meningioma
risk management
legislation, drug
medroxyprogesterone acetate
Drug-Related side effects and adverse reactions
medrogestone
progesterone congeners
medrogestone
medroxyprogesterone
drug prescriptions
Renewal of prescription (procedure)
professional role
physicians
pharmacists
summary of product characteristics
package leaflet
---
https://ansm.sante.fr/actualites/analogues-du-glp-1-point-sur-la-surveillance-des-effets-indesirables-graves-et-mesusages
2024
false
false
false
France
French
pharmacovigilance note
Glucagon-Like Peptide-1 Receptor Agonists
Serious Adverse Drug Reaction
product surveillance, postmarketing
pharmacovigilance
Drug Misuse
---
https://ansm.sante.fr/tableau-marr/acetate-de-nomegestrol
2024
false
false
false
France
French
drug information
risk management
nomegestrol acetate
nomegestrol
progesterone congeners
administration, oral
risk
meningioma
continuity of patient care
patients guideline
---
https://ansm.sante.fr/tableau-marr/acetate-de-chlormadinone
2024
false
true
false
France
French
risk management
meningioma
chlormadinone acetate
progesterone congeners
chlormadinone
drug information
patients guideline
continuity of patient care
mass screening
meningioma
risk
---
https://ansm.sante.fr/tableau-marr/medrogestone
2024
false
false
false
France
French
risk management
medrogestone
administration, oral
medrogestone
risk
meningioma
continuity of patient care
progesterone congeners
patients guideline
drug information
meningioma
---
https://ansm.sante.fr/tableau-marr/acetate-de-medroxyprogesterone
2024
false
false
false
France
French
risk management
medroxyprogesterone acetate
risk
meningioma
meningioma
injections, intramuscular
medroxyprogesterone
continuity of patient care
drug information
patients guideline
progesterone congeners
contraceptive agents, female
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-juillet-2024-8-11-juillet
2024
false
false
false
France
French
pharmacovigilance note
europe
Glatiramer Acetate
Glucagon-Like Peptide-1 Receptor Agonists
risk management
anesthesia, general
deep sedation
Aspiration Pneumonitis
anaphylaxis
---
https://ansm.sante.fr/actualites/ballons-gastriques-allurion-recommandations-pour-limiter-la-survenue-de-complications-graves
2024
false
false
false
France
French
equipment and supplies note
gastric balloon
continuity of patient care
Insertion of gastric balloon (procedure)
guideline
patients guideline
intestinal obstruction
Acquired obstruction of pylorus (disorder)
Pyloric Obstruction
Gastric Perforation
risk
risk management
---
https://www.cbip.be/fr/articles/4380?folia=4379
2024
false
false
false
Belgium
French
journal article
drug information
europe
drug approval
lecanemab
alzheimer disease
risk
lecanemab
lecanemab
---
https://ansm.sante.fr/actualites/lansm-suspend-les-ballons-gastriques-allurion
2024
false
false
false
France
French
equipment and supplies note
guideline
gastric balloon
Safety-Based medical device withdrawals
france
---
https://ansm.sante.fr/dossiers-thematiques/topiramate-et-grossesse
2024
false
false
false
France
French
Topiramate
pregnancy
patients guideline
epilepsy
migraine disorders
Topiramate
guideline
risk
abnormalities, drug-induced
In Utero Drug Exposure
Female of Childbearing Potential
topiramate
---
https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy
---
https://ansm.sante.fr/informations-de-securite/acetate-de-glatiramere-des-reactions-anaphylactiques-peuvent-survenir-des-mois-voire-des-annees-apres-linstauration-du-traitement
2024
false
false
false
France
French
pharmacovigilance note
Glatiramer Acetate
glatiramer acetate
adjuvants, immunologic
anaphylaxis
Anaphylactic Reaction
injections, subcutaneous
multiple sclerosis, relapsing-remitting
---
https://ansm.sante.fr/dossiers-thematiques/covid-19-suivi-hebdomadaire-des-cas-deffets-indesirables-des-vaccins
2023
false
false
false
France
French
drug information
COVID-19
COVID-19 Vaccines
vaccination
anaphylaxis
Drug-Related side effects and adverse reactions
Covid-19 vaccines
---
https://ansm.sante.fr/informations-de-securite/codeine-ibuprofene-antarene-codeine-risque-datteintes-renales-gastro-intestinales-et-metaboliques-graves-devolution-parfois-fatale-en-cas-dabus-et-de-dependance-a-lantarene-codeine
https://ansm.sante.fr/actualites/antarene-codeine-codeine-ibuprofene-la-prise-prolongee-en-cas-dabus-et-de-dependance-peut-entrainer-une-toxicite-renale-et-intestinale-pouvant-conduire-au-deces
2023
false
false
false
France
French
pharmacovigilance note
drug combinations
codeine
ibuprofen
codeine and ibuprofen
administration, oral
codeine
opioid-related disorders
intestinal perforation
gastrointestinal hemorrhage
ibuprofen
renal insufficiency
hypokalemia
acidosis, renal tubular
anti-inflammatory agents, non-steroidal
analgesics, opioid
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2023-6-9-fevrier
2023
false
false
false
France
French
drug information
risk assessment
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
vasoconstrictor agents
administration, oral
---
PUBLIÉ LE 27/02/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/informations-de-securite/zolgensma-onasemnogene-abeparvovec-cas-dinsuffisance-hepatique-aigue-dissue-fatale
2023
false
false
false
France
French
pharmacovigilance note
risk
onasemnogene abeparvovec-xioi
Onasemnogene Abeparvovec
onasemnogene abeparvovec
liver function tests
continuity of patient care
Monitoring of liver function (regime/therapy)
liver failure, acute
child
infant
liver failure, acute
guidelines for drug use
---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma
---
https://ansm.sante.fr/tableau-marr/ranibizumab-1
2023
false
false
false
France
French
risk management
patient education handout
Ranibizumab
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release
solution for injection (clinical drug)
intravitreal injections
---
https://www.cbip.be/fr/articles/4045?folia=4031
2023
false
false
false
Belgium
French
journal article
proton pump inhibitors
---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation
---
https://ansm.sante.fr/tableau-marr/tofacitinib
2023
false
false
false
France
French
risk management
tofacitinib
tofacitinib
continuity of patient care
checklist
guidelines for drug use
patient education handout
Janus Kinase Inhibitors
tofacitinib
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
pregnancy
teratogens
Virus Reactivation
tuberculosis
neoplasms
embolism and thrombosis
herpes zoster
---
https://ansm.sante.fr/actualites/epi-phare-publie-dans-le-nejm-les-resultats-dune-etude-qui-montre-quil-ny-a-pas-daugmentation-du-risque-devenement-cardiovasculaire-grave-avec-les-vaccins-bivalents-contre-le-covid-19
2023
false
false
false
France
French
drug information
COVID-19 Vaccines
Bivalent Vaccines
mRNA Vaccines
cardiovascular diseases
---
PUBLIÉ LE 31/03/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-10-02-2023-au-16-03-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib
---
https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants
2023
false
false
false
France
French
guidelines for drug use
patient education handout
mydriatics
ophthalmic solutions
child
---
https://ansm.sante.fr/actualites/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance
2023
false
false
false
France
French
abnormalities, drug-induced
teratogens
pharmacovigilance note
pregnancy
hydroxychloroquine
risk
patient education handout
In Utero Drug Exposure
antirheumatic agents
---
https://ansm.sante.fr/informations-de-securite/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
https://ansm.sante.fr/actualites/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Janus Kinase Inhibitors
Chronic inflammatory disorder (disorder)
chronic disease
---
https://publications.msss.gouv.qc.ca/msss/document-003568/
2023
false
false
false
Canada
noise
guideline
noise
---
https://ansm.sante.fr/dossiers-thematiques/acne-severe-et-traitement-par-isotretinoine
2023
false
false
false
France
French
video recording
popular works
isotretinoin
administration, oral
isotretinoin
pregnancy
isotretinoin
teratogens
acne vulgaris
---
https://ansm.sante.fr/tableau-marr/filgotinib
2023
false
false
false
France
French
guidelines for drug use
risk management
filgotinib
administration, oral
patient education handout
filgotinib
filgotinib
Janus Kinase Inhibitors
adult
aged
pregnancy
breast feeding
Janus Kinase Inhibitors
arthritis, rheumatoid
---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout
---
https://ansm.sante.fr/tableau-marr/citrate-de-cafeine
2023
false
false
false
France
French
pharmacovigilance note
caffeine citrate
guidelines for drug use
infant, newborn
infusions, intravenous
infant, premature
caffeine citrate
sleep apnea, newborn, primary
Primary apnea in the newborn (finding)
sleep apnea, central
caffeine
citrates
caffeine
citrates
---
https://ansm.sante.fr/tableau-marr/chlorhydrate-de-mexiletine
2023
false
false
false
France
French
pharmacovigilance note
mexiletine hydrochloride
guidelines for drug use
risk management
mexiletine hydrochloride
arrhythmias, cardiac
hepatic insufficiency
mexiletine hydrochloride
patient education handout
Drug-Related side effects and adverse reactions
risk
continuity of patient care
mexiletine
mexiletine
mexiletine
---
https://ansm.sante.fr/tableau-marr/baclofene
2023
false
false
false
France
French
baclofen
baclofen
risk management
guidelines for drug use
patients guideline
patient education handout
continuity of patient care
drug monitoring
alcoholism
---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol
---
https://www.medsubhyp.fr/recommandations-en-sante-au-travail/
2023
false
false
false
France
French
consensus
adolescent
adult
pregnancy
hematologic diseases
cardiovascular diseases
respiratory tract diseases
eye diseases
skin diseases
tooth diseases
kidney diseases
gastrointestinal diseases
musculoskeletal diseases
otorhinolaryngologic diseases
occupational medicine
occupational medicine
occupational health physicians
return to work
government regulation
signs and symptoms
aged
hearing tests
respiratory function tests
risk assessment
accidents
barotrauma
barotrauma
occupational exposure
central nervous system diseases
occupational medicine
submarine medicine
mental disorders
work capacity evaluation
---
https://ansm.sante.fr/tableau-marr/alemtuzumab
2023
false
false
false
France
French
risk management
Alemtuzumab
Alemtuzumab
alemtuzumab
infusions, intravenous
continuity of patient care
multiple sclerosis, relapsing-remitting
guidelines for drug use
patients guideline
patient education as topic
Drug-Related side effects and adverse reactions
drug monitoring
clinical chemistry tests
thyroid diseases
purpura, thrombocytopenic, idiopathic
kidney diseases
anti-glomerular basement membrane disease
Infections
pregnancy
mass screening
Contraindications, Drug
premedication
---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care
---
https://www.ansm.sante.fr/actualites/anti-inflammatoires-non-steroidiens-ains-et-complications-infectieuses-graves
2023
false
false
false
France
French
pharmacovigilance note
anti-inflammatory agents, non-steroidal
Infections
fever
pain
ibuprofen
ketoprofen
adult
child
streptococcal infections
guidelines for drug use
---
https://www.cbip.be/fr/articles/4070?folia=4050
2023
false
false
false
Belgium
French
anticonvulsants
teratogens
pregnancy
journal article
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-16-03-2023-au-13-04-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://www.cbip.be/fr/articles/4075?folia=4050
2023
false
false
false
Belgium
French
journal article
administration, oral
ivermectin
ivermectin
antiparasitic agents
drug eruptions
epidermal necrolysis, toxic
stevens-johnson syndrome
pharmacovigilance note
---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound
---
https://www.cbip.be/fr/articles/4090?folia=4079
2023
false
false
false
Belgium
French
lactation disorders
journal article
pharmaceutical preparations
Drug-Related side effects and adverse reactions
breast feeding
---